IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asaduzzaman, M.
Right arrow Articles by Qadri, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asaduzzaman, M.
Right arrow Articles by Qadri, F.

 Previous Article  |  Next Article 

Infection and Immunity, August 2004, p. 4448-4454, Vol. 72, No. 8
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.8.4448-4454.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The Major Subunit of the Toxin-Coregulated Pilus TcpA Induces Mucosal and Systemic Immunoglobulin A Immune Responses in Patients with Cholera Caused by Vibrio cholerae O1 and O139

Muhammad Asaduzzaman,1 Edward T. Ryan,2 Manohar John,2 Long Hang,2 Ashraful I. Khan,1 A. S. G. Faruque,1 Ronald K. Taylor,3 Stephen B. Calderwood,2 and Firdausi Qadri1*

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh,1 Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts,2 Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire3

Received 16 February 2004/ Returned for modification 21 March 2004/ Accepted 10 April 2004

Diarrhea caused by Vibrio cholerae is known to give long-lasting protection against subsequent life-threatening illness. The serum vibriocidal antibody response has been well studied and has been shown to correlate with protection. However, this systemic antibody response may be a surrogate marker for mucosal immune responses to key colonization factors of this organism, such as the toxin-coregulated pilus (TCP) and other factors. Information regarding immune responses to TCP, particularly mucosal immune responses, is lacking, particularly for patients infected with the El Tor biotype of V. cholerae O1 or V. cholerae O139 since highly purified TcpA from these strains has not been available previously for use in immune assays. We studied the immune responses to El Tor TcpA in cholera patients in Bangladesh. Patients had substantial and significant increases in TcpA-specific antibody-secreting cells in the circulation on day 7 after the onset of illness, as well as similar mucosal responses as determined by an alternate technique, the assay for antibody in lymphocyte supernatant. Significant increases in antibodies to TcpA were also seen in sera and feces of patients on days 7 and 21 after the onset of infection. Overall, 93% of the patients showed a TcpA-specific response in at least one of the specimens compared with the results obtained on day 2 and with healthy controls. These results demonstrate that TcpA is immunogenic following natural V. cholerae infection and suggest that immune responses to this antigen should be evaluated for potential protection against subsequent life-threatening illness.


* Corresponding author. Mailing address: Laboratory Sciences Division, ICDDR,B, Mohakhali, Dhaka 1212, Bangladesh. Phone: 8802 8811751 to 8802 8811760, ext. 2431. Fax: 8802 8823116 or 8802 8826050. E-mail: fqadri{at}icddrb.org.

Editor: W. A. Petri, Jr.


Infection and Immunity, August 2004, p. 4448-4454, Vol. 72, No. 8
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.8.4448-4454.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.